Navigation Links
ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
Date:9/4/2007

production technology from one company to another, or from one country to another, can be a complex process. This milestone proves the commitment from both sides to use their substantial scientific skills to supply THR-100, a novel recombinant therapeutic, to the developing world. With this successful collaboration, we look forward to moving this unique thrombolytic agent quickly into the clinic and toward commercialization."

Commenting on the technology transfer, Dr. Krishna M. Ella, Chairman and Managing Director of Bharat Biotech, said, "Successful transfer of technology from ThromboGenics to Bharat Biotech is a significant milestone in the development of THR-100 as a novel thrombolytic agent. Bharat Biotech has significant expertise in executing technology transfer processes from U.S. and EU companies. We are highly excited about further clinical development of THR-100 and its commercialization."

About ThromboGenics

ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke. ThromboGenics also has one program, TB-402 (Anti-Factor VIII), in Phase I clinical trials, and three other drug candidates in preclinical development with preclinical proof-of-principle demonstrated. ThromboGenics has built strong links with the University of Leuven and has exclusive rights to certain therapeutics developed at the University. ThromboGenics is headquartered in Leuven, Belgium and has subsidiaries in Dublin, Ireland, and New York, U.S. The Company is listed on Eurolist by Euronext Brussels under the symbol THR. More information is available at http://www.thrombogenics.com.'/>"/>

SOURCE ThromboGenics NV
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...ire/ -- The Eniva Research Group has,released resu...us Pauling,Micronutrient Research Institute at Ore...Health Supplement VIBE(R) possessed DNA protective...rd party testing was,performed as part of an ongoi...isms by which the Eniva VIBE nutraceutical impacts...
(Date:7/3/2008)...e/ - OncoGenex Technologies Inc. and Isis,Pharmace...t the companies,have amended their agreement and O...lead cancer drug OGX-011. Under the amended agreem...e development activities,costs and partnering dec...responsible for funding 35% of development costs, ...
(Date:7/3/2008)...wswire-FirstCall/ -- AMDL, Inc. (Amex:,ADL), a wor...ed in Tustin,Ca., with operations in Shenzhen, Ji...leased its investor presentation which is availabl...www.amdl.com ., About AMDL:, AMDL, Inc. is a glo...is,headquartered in Tustin, California with operat...
(Date:7/2/2008)... Stent to Demonstrate Superiority Over,Market-Lead...ted States for Treatment of Coron...Newswire-FirstCall/ -- Abbott today,announced that...ved the,XIENCE(TM) V Everolimus Eluting Coronary S...isease. XIENCE V is the only drug eluting stent to...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...s. - Two of the largest U.S.-based multi-national...Milwaukee County Research Park . , , Johnson Contr...the park, according to Dave Domres, vice president...ers, LLC . , ,Johnson Controls, a Milwaukee-based...lobal manufacturer of automotive systems, plans to...
...es with Google , Yahoo , and MSN have marketer..., ,In recent months, popular search engines have u...ers to target specific ad positions within search ...results; and Yahoo announced a partnership with eB...ting search engines remains uncertain, it,s certai...
...article, we looked at the leading pharmaceutical c...cal market, which for the first time surpassed $6...rt of equation, as another significant market is t...e numbers on the size of the total medical device ... $200 billion in annual revenue in 2005, as the to...
... - Since its inception, Venture Investors has e...at was popularized on the coasts, and it now has a...arly-stage businesses. , ,The Madison-based ventur... from mostly Wisconsin sources for its new Venture... and already is in discussions with several prospe...
Other Biology Technology:Location, location, location: Spots to consider for online ads 2Location, location, location: Spots to consider for online ads 3Location, location, location: Spots to consider for online ads 4Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7Venture Investors looks to fund 20 companies 2Venture Investors looks to fund 20 companies 3
(Date:7/2/2008)... to produce a lot of a substance -- such as a newl...olecules that speed chemical reactions. Many jobs ...one in just the right shape to connect with certai...uch as enzymes in the human body that help us dige... to suit the task at hand. , Chemists have made ...
(Date:7/2/2008)...n . , Metabolomics aims to determine the totalit...e exponents of bioinformatics analyzed data collec...s study in healthy and diabetic mice. In each case...iabetes drug RoziglitazoneTM. Then, more than 800 ...ood plasma sample of a total of forty mice, repres...
(Date:7/2/2008)...ish . , Most of the functions performed by a ce..., which recognise their binding partner by affinit... are many kinds of interactions; however, the most...ctural biology are those which are transient. This... large section of the protein surface- the globula...
(Date:7/2/2008)...its kind, using sophisticated methods to measure b...eight loss program, Weight Watchers, was compared ...d wins in the game of good health. A University of...ences of participants to determine which program h...health benefits. The answer is that both have pros...
Breaking Biology News(10 mins):Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Weight Watchers vs. fitness centers 2Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 3414 1Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 3414 2Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 1Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 2Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 3Understanding autumn rain decline in SE Australia 3411 1Understanding autumn rain decline in SE Australia 3411 2TriWest Teaches California Kids About Veterans Sacrifice Courage 20159 1TriWest Teaches California Kids About Veterans Sacrifice Courage 20159 2
...particles weaken the bonding of hip, knee, and oth...shed online in Proceedings of the National Academy...alifornia, San Diego (UCSD) School of Medicine and...trated that titanium implants are safe in large bl...can generate micrometer-sized particles. , "As re...
...overed a fascinating symbiotic relationship betwee...species ?a relationship that potentially sheds lig... higher organisms in defensive mechanisms against ...that a solitary ground-nesting wasp, the European ...tructures within its antennae and that females uti...
...t imaging technology a team from Yale School of Me...nt ,nano-machines, in action. The work, performed ...s, provides new insight into the machinery cells u...lls traffic protein cargos across their outer memb...go internalization is clathrin mediated endocytosi...
...lished in the Journal of Biological Chemistry, sci...to play a purely structural and inert role in cell...cancer. Using antagonists for this molecule, the r...reast cancer cells to chemotherapeutic drug treatm...Week" in the May 27 issue of the Journal of Biolog...
Other Biology News:UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints 2Symbiotic bacteria protect hunting wasps from fungal infestation 2Researchers develop assay that could be applied to drug screening 2New polysaccharide may help combat multidrug resistance in cancer 2
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells.
Request Info
Vesicle Associated Membrane Protein (VAMP 1/2)
Human / Porcine Endothelin 1 from AnaSpec
Biology Products: